Kopernik Global Investors, LLC Abb Vie Inc. Put Options Transaction History

Kopernik Global Investors, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $1.41 Million - $1.6 Million	-8,800 Reduced 52.38%	8,000 $1.46 Million
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $2.43 Million - $2.8 Million	16,800 New	16,800 $2.68 Million
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $282,510 - $361,114	-4,300 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $435,659 - $484,316	-4,900 Reduced 53.26%	4,300 $108,000
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $846,492 - $1.13 Million	9,200 New	9,200 $252,000

3,695

1.27B

13M

9.79M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $349B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Kopernik Global Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Kopernik Global Investors, LLC with notifications on news.